Skip to main content
Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc logoLink to Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
. 2021 May 13;33(4):767–771. doi: 10.1177/10406387211015640

Immunohistochemical characterization of mesothelioma in 6 large felids

Sarah E Coe 1, Michael M Garner 2, Matti Kiupel 3,1
PMCID: PMC8229833  PMID: 33980074

Abstract

Mesothelioma has been reported frequently in large felids. These neoplasms present a diagnostic challenge given their highly variable morphology that mimics carcinomas or sarcomas at different locations. Our goal was to characterize mesotheliomas morphologically and immunohistochemically to determine if a panel of antibodies could be used to more accurately support the diagnosis of these neoplasms in large felids. Mesotheliomas from 6 large felids, including 4 clouded leopards, 1 Bengal tiger, and 1 cheetah, were immunohistochemically labeled for vimentin, E-cadherin, pancytokeratin, Wilms tumor 1 (WT1), MUC-1, and calretinin. The mesotheliomas of the 4 clouded leopards and the tiger were of the epithelial subtype; the mesothelioma from the cheetah was biphasic. All 6 mesotheliomas had strong immunohistochemical labeling for vimentin, E-cadherin, and pancytokeratin. All cases had cytoplasmic labeling for WT1, and 2 also had nuclear labeling. The 3 mesotheliomas with distinct papillary fronds were weakly positive for MUC-1. These and one other epithelial mesothelioma were also positive for calretinin. Our study demonstrates that the morphologic and immunohistochemical phenotypes of mesothelioma that have been identified in humans and domestic species can occur in large felids, and a panel of pancytokeratin, vimentin, WT1, and calretinin can be utilized to support the diagnosis of these neoplasms.

Keywords: calretinin, immunophenotype, large felids, mesothelioma, WT1


Mesotheliomas are malignant neoplasms that arise from mesothelial cells that cover the pleural, peritoneal, and pericardial surfaces. Such neoplasms present a diagnostic challenge, given that they can be difficult to distinguish from reactive mesothelium or from various types of sarcomas or carcinomas. Mesotheliomas occur uncommonly in domestic species,2,79,19 but have been reported more commonly in humans in association with asbestos exposure. 13 Mesotheliomas have also been reported in large felids from zoological collections3,11,12,18,20; however, little immunohistochemical characterization of these neoplasms has been performed. We characterized the gross, histologic, and immunohistochemical features of mesotheliomas in 6 large felids from zoological institutions in the United States.

There are 3 main histologic types of mesothelioma: epithelial, sarcomatous, and biphasic. Depending on the morphologic subtype and their location, mesotheliomas must be differentiated from sarcomas or carcinomas arising in similar locations. Immunoreactivity for both epithelial and mesenchymal markers is characteristic of mesothelioma, and panels of antibodies are most useful in the diagnosis of mesotheliomas.1,2,5,14,16,17 In human medicine, antibodies that are commonly expressed by mesotheliomas include carcinoembryonic antigen (CEA), Ber-EP4, B72.3, CD15, MOC-31, thyroid transcription factor 1, cytokeratin (CK) 5/6, calretinin, HBME-1, thrombomodulin, Wilms tumor 1 (WT1), mesothelin, D2-40, and podoplanin.13,15,16 In domestic cats, antibodies that have been demonstrated to be expressed by mesotheliomas are vimentin, CK AE1/AE3, HBME-1, CK 5/6, CEA, and E-cadherin. 2

Six cases of mesothelioma in large felids were identified in archived records from Northwest ZooPath (Monroe, WA, USA; Table 1). The mesotheliomas originated from 4 clouded leopards (Neofelis nebulosa), 1 Bengal tiger (Panthera tigris tigris), and 1 cheetah (Acinonyx jubatus). There were 4 females and 2 males, aged 12–21 y old. All mesotheliomas occurred as primary intrathoracic masses (Figs. 1, 2), and one metastasized to thoracic lymph nodes, the bone of the rib, adrenal glands, kidney, and lung. Pleural effusions were reported for 4 cases.

Table 1.

Case demographics and autopsy findings.

Case Species Sex Age (y) Site Autopsy findings
1 Clouded leopard Male 14 Mediastinum Thoracic mass occupying the mediastinum; pleural and peritoneal serosanguineous effusion
2 Clouded leopard Male 13 Pleura Pleura covered in masses with a granular appearance; nodules on pericardium; nodule in lung
3 Clouded leopard Female 18 Pleura Pleural effusion, cauliflower-like lesions on the pleura and diaphragm; scattered nodules on pleura, lung, and heart
4 Clouded leopard Female 12 Pleura Pleural effusion and mass on left caudal lung lobe; small masses on all surfaces of thoracic cavity
5 Bengal tiger Female 21 Mediastinum, lung Nodular mass in the thoracic inlet obstructing the esophagus; similar nodules in the lungs
6 Cheetah Female 12 Mediastinum, pleura, pericardium Pleural effusion, mediastinal, pleural, pulmonary, pericardial masses; distant metastases present

Figures 1–10.

Figures 1–10.

Epithelioid mesothelioma in a clouded leopard, case 1. Figure 1. The mediastinum and visceral pleura are covered by large numbers of pale-tan nodules. Figure 2. The parietal pleura is covered by myriad individual-to-coalescing, pale-tan to red nodules. Figure 3. Epithelioid mesothelioma in a clouded leopard, case 2. Neoplastic cells arranged in papillary fronds supported by fibrovascular stroma. H&E. Figures 4, 5. Biphasic mesothelioma in a cheetah, case 6. Figure 4. Neoplastic cells form a solid sheet. H&E. Figure 5. Spindloid neoplastic cells form sheets in some areas. H&E. Figures 6, 7. Epithelioid mesothelioma in a clouded leopard, case 2. Figure 6. Neoplastic cells with strong cytoplasmic labeling for vimentin. Red chromogen, hematoxylin counterstaining. Figure 7. Neoplastic cells with strong cytoplasmic labeling for pancytokeratin. DAB, hematoxylin counterstaining. Figure 8. Biphasic mesothelioma in a cheetah, case 6. Neoplastic spindle cells with strong cytoplasmic labeling for pancytokeratin. DAB, hematoxylin counterstaining. Figure 9. Epithelioid mesothelioma in a tiger, case 5. Neoplastic cells have cytoplasmic and nuclear labeling. WT1. DAB, hematoxylin counterstaining. Figure 10. Epithelioid mesothelioma in a clouded leopard, case 2. Neoplastic cells with cytoplasmic labeling for calretinin. DAB, hematoxylin counterstaining.

Hematoxylin and eosin (H&E)-stained sections were reviewed, to reaffirm the histologic diagnosis. The paraffin-embedded tissue blocks were sent to Michigan State University (Lansing, MI, USA) where representative areas from each case were selected from the original donor block and transferred into a single paraffin block that combined all 6 cases. A section from the block stained with H&E was examined to confirm that neoplastic cells were present from each case. Immunohistochemistry (IHC) for vimentin, pancytokeratin, calretinin, WT1, E-cadherin, and epithelial membrane antigen (EMA, MUC-1) was performed on serial sections from the composite tissue block. IHC was performed for calretinin, E-cadherin, pancytokeratin, and WT1 (BOND-MAX automated staining system, Bond polymer detection system, Vision BioSystems; Leica) with 3,3′-diaminobenzidine (DAB) as the chromogen; for MUC-1 (Dako link 48 automated staining system, peroxidase-conjugated EnVision polymer detection system; Agilent Technologies); and for vimentin (Discovery Ultra automated staining system, UltraMap alkaline phosphatase red detection system; Ventana Medical Systems; Table 2). Non-neoplastic mesothelium from a large felid was used as the positive control for all antibodies. Cases were considered positive for vimentin, pancytokeratin, MUC-1, and calretinin if there was cytoplasmic labeling of neoplastic cells. Cases were considered positive for E-cadherin if there was membranous labeling of neoplastic cells. Cases were considered positive for WT1 if there was cytoplasmic labeling with or without nuclear labeling.

Table 2.

List of antibodies with source, clone, concentration used, retrieval information, and detection method.

Antibody Host Source Clone Antigen retrieval Dilution Chromogen
Vimentin Mouse Roche, 790-2917 V9 CC1* RTU UltraMap red
E-cadherin Mouse BD Biosciences, 610181 36/E-cadherin ER1 1:300 DAB
Pancytokeratin Mouse Agilent, M0821 MNF116 E2§ 1:800 DAB
Wilms tumor 1 Rabbit Abcam, ab15249 Polyclonal ER2¦ 1:500 DAB
Calretinin Mouse Agilent, M7245 DAK-Calret 1 ER1 1:100 DAB
MUC-1 Rabbit LSBio, LS-C30532 Polyclonal Low PT# 1:500 DAB
*

Heat retrieval for 4 min (CC1 = cell conditioning 1, Discovery Ultra; Ventana).

Ready to use.

Heat retrieval for 20 min (ER1 = Bond epitope retrieval solution 1; Leica Biosystems).

§

Enzymatic antigen retrieval for 20 min (E2; Agilent Technologies).

¦

Heat retrieval for 20 min (ER2 = Bond epitope retrieval solution 2; Leica Biosystems).

#

Low pH retrieval for 20 min (Dako PT link; Agilent Technologies).

Histologically, the mesotheliomas in the clouded leopards and the tiger (cases 1–5) were epithelial mesotheliomas. The neoplastic cells in these cases were arranged in tubules and papillary fronds supported by variable amounts of fibrovascular stroma. The cells were polygonal, with moderate amounts of eosinophilic cytoplasm, and distinct cell borders. The nuclei were round-to-ovoid, had finely stippled to vesiculate chromatin, and 1–3 nucleoli. Two mesotheliomas in clouded leopards (cases 2, 3) and the mesothelioma in the tiger (case 5) had large prominent papillary fronds (Fig. 3).

The mesothelioma in the cheetah (case 6) was biphasic and had an area of solid epithelial neoplastic cells (Fig. 4) and sarcomatous neoplastic cells (Fig. 5). In the solid area, the cells were arranged in a dense sheet with scant fibrovascular stroma. These cells were polygonal, had a moderate amount of eosinophilic cytoplasm, and had distinct cell borders. The nuclei were round-to-ovoid, finely stippled to vesiculate, and had 1–3 nucleoli. Anisokaryosis in this area was moderate, and there were multinucleate cells. In the sarcomatous area, the cells were arranged in dense bundles. The cells were spindloid, had a small amount of eosinophilic cytoplasm, and had indistinct cell borders. The nuclei were ovoid-to-elongate, finely stippled, and had 1 or 2 nucleoli. Anisokaryosis was mild in this area.

The diagnosis of mesothelioma was confirmed with positive immunoreactivity for vimentin, pancytokeratin, WT1, and E-cadherin in all cases (Table 3). These cases had diffuse positive cytoplasmic labeling for vimentin (Fig. 6), pancytokeratin (Figs. 7, 8), and WT1 (Fig. 9), and membranous labeling for E-cadherin along the surface of the neoplasm; in case 6, there was membranous labeling of cells invading the stroma and impinging on vessels. Two epithelial mesotheliomas in a clouded leopard and in the tiger (cases 4, 5) also had positive nuclear labeling for WT1 (Fig. 9). The 3 mesotheliomas with distinct papillary fronds (cases 2, 3, 5) were weakly positive for MUC-1 with patchy superficial cytoplasmic labeling, and these mesotheliomas, in addition to another epithelial tumor (case 4), were positive for calretinin with patchy cytoplasmic labeling (Fig. 10).

Table 3.

Histologic and immunohistochemical findings in mesotheliomas in 6 large felids.

Case Histologic type Vimentin Pancytokeratin WT1 E-cadherin Calretinin MUC-1
1 Epithelioid, tubulopapillary + + + +
2 Epithelioid, tubulopapillary + + + + + +
3 Epithelioid, tubulopapillary + + + + +
4 Epithelioid, tubulopapillary + + + + + +
5 Epithelioid, tubulopapillary + + + + + +
6 Biphasic + + + +

Given that the histologic features of mesothelioma are variable and often do not allow differentiation from either sarcomas or carcinomas, IHC is commonly needed to confirm the diagnosis. The infrequency of reported cases of mesothelioma in veterinary medicine poses an additional challenge to the diagnostician. Positive labeling for epithelial and mesenchymal markers is characteristic of mesotheliomas.1,2,5,14,16,17 Positive labeling for pancytokeratin in mesenchymal mesotheliomas helps to distinguish these cases from sarcomas or a marked scirrhous response. Although labeling for pancytokeratin and vimentin in epithelial mesotheliomas aids in distinguishing them from carcinomas, it is not a feature unique to mesotheliomas and can be observed commonly in some carcinomas, such as pulmonary carcinoma, a primary differential of thoracic mesotheliomas. 4 Therefore, additional antibodies are commonly needed to further support a diagnosis of mesothelioma or to exclude the specific primary differentials that may vary based on location and morphology of the mesothelioma.

All mesotheliomas in our series were also positive for E-cadherin, and this antibody may be used as an alternative or additional epithelial marker. MUC-1 (EMA) is another marker of epithelial lineage and had been proposed in human medicine to differentiate malignant from benign mesothelial proliferations. Although increased expression of MUC-1 has been reported in malignant mesothelial proliferations, the immense variation in expression between benign and malignant mesothelial lesions made MUC-1 a less useful marker to identify malignant mesotheliomas.14,16 In our study, MUC-1 labeled the 3 mesotheliomas with the most differentiated tubulopapillary pattern. Although MUC-1 may be useful as part of a panel to help distinguish mesotheliomas from sarcomas, it is of little benefit to differentiate mesotheliomas from carcinomas given that the reaction patterns of different carcinomas in large felids are mainly unknown.

Two of the more discriminating antibodies in our study included WT1 and calretinin. The WT1 gene is a tumor suppressor gene originally discovered as a mutation in Wilms tumors in humans. In humans, in addition to labeling Wilms tumor, this antibody has been proven useful to distinguish neoplastic mesothelial cells.10,13,14,16,17 All 6 mesotheliomas in our study had cytoplasmic labeling for WT1, and 2 cases had nuclear labeling, confirming that this antibody may be useful in the diagnosis of mesotheliomas in large felids. In the human literature, it is reported that nuclear labeling for WT1 is required to differentiate mesothelioma from carcinoma. Cytoplasmic labeling can also be observed in mesothelioma; however, this is less specific, and some adenocarcinomas may have cytoplasmic labeling. 10 Calretinin is a calcium-binding protein that plays a role in cell-signaling, buffering intracellular calcium levels, and neuronal excitability. 6 In addition to expression in neuronal tissue, it is also expressed in mesothelium. This antibody is considered one of the more sensitive and specific markers for mesothelioma in human medicine and is routinely included in diagnostic mesothelioma panels.6,10,16,17 Although in our study, only 4 of the 6 cases were positive, especially in neoplasms that were also positive for pancytokeratin and vimentin, calretinin essentially confirmed the diagnosis of mesothelioma. Interestingly, the only biphasic mesothelioma in our series was negative for calretinin. The other negative mesothelioma was a less well-differentiated tubulopapillary mesothelioma.

Mesotheliomas represent a diagnostic challenge, even for experienced pathologists. Although morphologic features are important to establish mesothelioma as a differential diagnosis, IHC is essential to confirm the diagnosis. Depending on the morphologic subtype of mesothelioma and its location, differentials may vary, and different panels of antibodies will be necessary to exclude such differentials. A panel composed of pancytokeratin, vimentin, WT1, and calretinin may be most helpful in aiding the diagnosis of mesothelioma in large felids.

Footnotes

Declaration of conflicting interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors received no financial support for the research, authorship, and/or publication of this article.

Contributor Information

Sarah E. Coe, Michigan State University Veterinary Diagnostic Laboratory and Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Lansing, MI, USA

Michael M. Garner, Northwest ZooPath, Monroe, WA, USA

Matti Kiupel, Michigan State University Veterinary Diagnostic Laboratory and Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Lansing, MI, USA.

References

  • 1. Attanoos RL, et al. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology 2000;37:224–231. [DOI] [PubMed] [Google Scholar]
  • 2. Bacci B, et al. Ten cases of feline mesothelioma: an immunohistochemical and ultrastructural study. J Comp Pathol 2006;134:347–354. [DOI] [PubMed] [Google Scholar]
  • 3. Bollo E, et al. Malignant pleural mesothelioma in a female lion (Panthera leo). Res Vet Sci 2011;91:116–118. [DOI] [PubMed] [Google Scholar]
  • 4. Burgess HJ, Kerr ME. Cytokeratin and vimentin co-expression in 21 canine primary pulmonary epithelial neoplasms. J Vet Diagn Invest 2009;21:815–820. [DOI] [PubMed] [Google Scholar]
  • 5. Cury PM, et al. Value of the mesothelium-associated antibodies, thrombomodulin, cytokeratin 5/6, calretinin and CD44 H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 2000;13:107–112. [DOI] [PubMed] [Google Scholar]
  • 6. Doglioni AP, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037–1046. [DOI] [PubMed] [Google Scholar]
  • 7. Fletcher N, et al. Mesothelioma in two sheep with pericardial effusion and ascites. Vet Rec Case Rep 2020;8:e001031. [Google Scholar]
  • 8. Gumber S, et al. Disseminated sclerosing peritoneal mesothelioma in a dog. J Vet Diagn Invest 2011;23:1046–1050. [DOI] [PubMed] [Google Scholar]
  • 9. Heerkens TM, et al. Peritoneal fibrosarcomatous mesothelioma in a cat. J Vet Diagn Invest 2011;23:593–597. [DOI] [PubMed] [Google Scholar]
  • 10. Husain AN, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2018;142:89–108. [DOI] [PubMed] [Google Scholar]
  • 11. Junginger J, et al. Pathology in captive wild felids at German zoological gardens. PLoS One 2015;10:e0130573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Kloft AM, et al. Neoplasia in captive Panthera species. J Comp Pathol 2019;166:35–44. [DOI] [PubMed] [Google Scholar]
  • 13. Kumar-Singh S, et al. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J Pathol 1997;181:67–74. [DOI] [PubMed] [Google Scholar]
  • 14. Marchevsky AM. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med 2008;132:397–401. [DOI] [PubMed] [Google Scholar]
  • 15. McCaughey WTE, et al. Tumors and pseudotumors of the serous membranes. (Atlas of Tumor Pathology. Second Series, Fascicle 20). Armed Forces Institute of Pathology, 1985:1–124. [Google Scholar]
  • 16. Ordonez NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol 2007;38:1–16. [DOI] [PubMed] [Google Scholar]
  • 17. Ordonez NG. Immunohistochemical diagnosis of epithelioid mesothelioma: a critical review of old markers, new markers. Hum Pathol 2002;33:953–967. [DOI] [PubMed] [Google Scholar]
  • 18. Shin NS, et al. Metastatic malignant mesothelioma in a tiger (Panthera tigris). J Zoo Wildl Med 1998;29:81–83. [PubMed] [Google Scholar]
  • 19. Son NV, et al. Sarcomatoid mesothelioma of tunica vaginalis testis in the right scrotum of a dog. J Vet Med Sci 2018;80: 1125–1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Souza FAL, et al. Peritoneal mesothelioma in a jaguar (Panthera onca). J Zoo Wildl Med 2013;44:737–739. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc are provided here courtesy of SAGE Publications

RESOURCES